Activation of the renin-angiotensin-aldosterone system (RAAS) is associated with increased circulating PAI-1 antigen and increased risk of thrombotic cardiovascular events. A 4G/5G polymorphism located 675 bp upstream from the transcription start site of the PAI-1 gene affects PAI-1 antigen concentrations. To test the hypothesis that PAI-1 4G/5G genotype influences the effect of activation of the RAAS on PAI-1 expression, we measured morning PAI-1 antigen concentrations in 76 subjects with essential hypertension during low (10 mmol/d) and high (200 mmol/d) salt intake. Low salt intake was associated with activation of the RAAS as measured by plasma renin activity (2.3Ϯ0.2 versus 0.5Ϯ0.0 ng angiotensin I · mL Ϫ1 · h Ϫ1 , PϽ0.001) and aldosterone (529Ϯ40 versus 145Ϯ12 pmol/L). PAI-1 antigen concentrations were 17.9Ϯ2.7, 19.2Ϯ2.5, and 27.8Ϯ4.0 ng/mL during high salt intake and 19.2Ϯ2.7, 21.6Ϯ2.9, and 38.9Ϯ7.2 ng/mL during low salt intake in the 5G/5G (nϭ14), 4G/5G (nϭ40), and 4G/4G (nϭ22) groups, respectively. There was a significant effect of both salt intake (Fϭ6.0, Pϭ0.017) and PAI-1 4G/5G genotype (Fϭ7.6, Pϭ0.001) on PAI-1 antigen. More importantly, there was a significant interactive effect (Fϭ7.8, Pϭ0.001) of salt intake and PAI-1 4G/5G genotype on PAI-1 antigen. PAI-1 4G/5G genotype influenced the relationship between serum triglycerides and PAI-1 antigen such that the relationship was significant only in 4G homozygotes during either high (R 2 ϭ0.31, Pϭ0.014) or low (R 2 ϭ0.37, Pϭ0.006) salt intake. This study identifies an important gene-by-environment interaction that may influence cardiovascular morbidity and the response to pharmacological therapies that interrupt the
A ctivation of the renin-angiotensin-aldosterone (RAAS) system has been associated with an increased risk of myocardial infarction (MI) and stroke in patients with essential hypertension. 1, 2 Conversely, interruption of the RAAS by ACE inhibition reduces the risk of MI in patients at risk for coronary artery disease. 3 Recent studies suggest that the effects of activation and interruption of the RAAS on cardiovascular morbidity and mortality derive in part from an interaction of the RAAS and fibrinolytic systems. 4, 5 Endogenous fibrinolysis plays a critical role in limiting thrombosis and depends on the balance between plasminogen activators (primarily tissue plasminogen activator, tPA) and plasminogen activator inhibitors (PAI, predominantly PAI-1). 6, 7 Both of these essential fibrinolytic components are synthesized locally in the vascular wall (in endothelial and smooth muscle cells), have short half-lives, and circulate in trace concentrations in the plasma. Increased PAI-1 expression has been demonstrated in atherosclerotic lesions. 8, 9 Elevated PAI-1 concentrations are seen in youthful survivors of acute MI compared with age-matched control subjects, 10 and elevated levels of PAI-1 appear to be a risk factor for recurrent MI. 11 PAI-1 antigen and activity are increased in patients with insulin resistance and may contribute to the increased mortality due to cardiovascular disease in this group. 12 Our group and others have shown that angiotensin (Ang) II and aldosterone stimulate PAI-1 expression, whereas ACE inhibition decreases PAI-1 both in vitro and in vivo. 4, 5, [13] [14] [15] A common single 4/5 guanine (4G/5G) polymorphism located 675 bp upstream from the transcription start site of the PAI-1 gene that influences PAI-1 production has been described. 16 PAI-1 antigen and activity are highest in individuals who are homozygous for the 4G allele and lowest in those homozygous for the 5G allele. In case-control studies, the prevalence of the 4G allele is significantly higher in young patients with MI than in population-based control subjects, 17 although studies in older patients have not uniformly confirmed an association between PAI-1 4G/5G genotype and coronary thrombotic events. 18 -20 The mechanism underlying allelic differences in PAI-1 production has been explained by the observation that both the 4G and 5G alleles bind a transcriptional activator, whereas the 5G allele also binds a transcriptional repressor. 17 Therefore, in the absence of the bound repressor, the basal level of PAI-1 transcription is increased. Furthermore, studies using reporter constructs have shown that the 4G allele produces 6 times more mRNA than the 5G allele in response to interleukin-1. 21 Studies in patients with insulin resistance suggest that PAI-1 4G/5G genotype influences the relationship between triglycerides and PAI-1 expression. 22 Furthermore, there is a concentration-response relationship between glucose and plasma PAI-1 in 4G/4G homozygotes. 22 The present study tests the hypothesis that the PAI-1 4G/5G polymorphism also modulates the effect of activation of the RAAS on PAI-1 expression in patients with essential hypertension.
Methods

Subjects
Subjects with essential hypertension were studied. Informed consent was obtained, and the study was approved by the Brigham and Women's Hospital Institutional Review Board and conducted according to the Declaration of Helsinki. Each subject underwent a history, physical examination, ECG, and laboratory analysis. Subjects were defined as hypertensive if they had a diastolic blood pressure of Ն90 mm Hg and had had hypertension for Ն6 months. Patients with secondary forms of hypertension, diabetes mellitus, renal insufficiency, or any significant medical illness were excluded. ACE inhibitors were discontinued for 3 weeks and all other antihypertensive medications were discontinued for 2 weeks before initiation of the study protocol.
General Protocol
All subjects participated in a protocol designed to phenotype them according to their response to exogenous Ang II, described in detail elsewhere. 23 In brief, subjects were supplied a caffeine-and alcoholfree diet providing a daily intake of 200 mmol sodium (high salt), 100 mmol potassium, 800 mg calcium, and 200 to 300 g carbohydrate for 7 days. Blood was obtained on the morning of day 5 for measurement of fasting insulin, glucose, cholesterol, and triglycerides. On the morning of day 8, blood was drawn through an indwelling catheter for measurement of plasma renin activity (PRA), aldosterone, Ang II, cortisol, and PAI-1 antigen after the subject had fasted overnight and had remained supine for 1 hour. Blood was also obtained for extraction of genomic DNA. Subjects were then given intravenous infusions of para-aminohippurate for measurement of renal blood flow and Ang II as previously described. 23 After completion of the high-salt diet, subjects were provided a low-salt (10 mmol/d) diet for an additional 7 days. Dietary potassium, calcium, and carbohydrate intake were held constant. Fasting insulin and glucose concentration measurements were repeated on day 5 of the diet. In addition, PRA and aldosterone concentrations were measured through an indwelling catheter after each subject had been supine for 1 hour and after 2 hours of ambulation. On day 7, blood was again obtained for measurement of PRA, aldosterone, Ang II, cortisol, PAI-1, and tPA antigen before para-aminohippurate and Ang II infusions. Dietary compliance was assessed by 24-hour urine collection at the end of each diet period.
Laboratory Analysis
All supine samples were collected between 8:00 and 9:00 AM. Blood samples were collected in chilled tubes and immediately centrifuged at 0°C at 3000 RPM for 20 minutes; plasma was then stored at Ϫ70°C until the time of assay. Blood for measurement of PAI-1 and tPA antigen was collected in chilled tubes containing 0.105 mol/L sodium citrate, and antigen levels were determined with a 2-site ELISA (Biopool AB) as previously described. In 54 subjects (11 5G/5G, 31 4G/5G, 12 4G/4G), plasma obtained during low salt intake was also assayed for tPA antigen by 2-site ELISA (Biopool AB). Blood for PRA and Ang II was collected in chilled tubes containing EDTA. PRA was determined by radioimmunoassay measurement of Ang I generated at 37°C, pH 6.0 (INCSTAR Corp).
Ang II was measured in 38 of 76 subjects (6 5G/5G, 18 4G/5G, 14 4G/4G). Urea (4 mmol/L) was added to plasma samples before freezing to block the formation or degradation of Ang II, and Ang II was measured by high-performance liquid chromatography as previously described. 24 Serum aldosterone (Diagnostic Corp) and cortisol (INCSTAR Corp) levels were assayed with commercially available radioimmunoassay kits. Glucose and insulin were measured by colorimetry (Johnson & Johnson Clinical Diagnostics) and radioimmunoassay (Tosoh Medics, Inc), respectively. Sodium and potassium were measured by direct potentiometry with an ionselective electrode (NOVA Analyzer I, NOVA Biochemical). Creatinine was measured with a Beckman model II creatinine analyzer.
PAI-1 4G/5G Genotyping
A commercially available process (Qiagen Inc) was used for the extraction of DNA from EDTA-anticoagulated blood. The PAI-1 4G/5G polymorphism was genotyped with a 25-L mixture containing standard polymerase chain reaction (PCR) buffer, 10 mmol/L dNTP, 4 mol/L primers, 0.4 U Taq polymerase, and 25 ng genomic DNA and previously published primers, 5Ј-CACAGAG AGAGTCTGGCCACGT-3Ј and 5Ј-CCAACAGAGGACTC-TTGGTCT-3Ј. The upstream primer was modified by substituting a cytosine for adenine at position Ϫ681, thereby introducing a BslI restriction site in the presence of the 5G but not the 4G allele. After BslI digestion for 2.5 hours at 55°C, PCR products were separated on a 3% agarose gel, stained with ethidium bromide, and visualized under ultraviolet light. The 4G allele corresponded to the presence of an uncut 98-bp product and the 5G allele to 77-and 22-bp fragments. A DNA sample known to be heterozygous for 4G/5G was used as a control.
Statistical Analysis
Data are presented as meanϮSEM. The effect of salt intake on specific endocrine or fibrinolytic variables was determined with a paired Student's t test. PAI-1 genotype frequencies were compared with expected frequencies by 2 analysis. The effect of PAI-1 genotype on endocrine or fibrinolytic variables was determined by 1-way ANOVA followed by Bonferroni's test. The interactive effect of salt intake and PAI-1 genotype on PAI-1 antigen was assessed by repeated-measures ANOVA in which the within-subject variable was salt intake and the between-subject variable was PAI-1 genotype. Pearson's or Spearman's correlation coefficients were used to examine simple relationships among variables, as appropriate. Multiple linear regression analysis was carried out to evaluate the possibility of interactions among variables affecting PAI-1 antigen. In the model, PAI-1 4G/5G genotype was coded by dummy variables as follows: PAI-1 4G/4G was 1 for 4G/4G individuals and 0 for 4G/5G and 5G/5G individuals; PAI-1 5G/5G was 1 for 5G/5G individuals and 0 for 4G/5G and 4G/4G individuals. A value of PϽ0.05 was considered statistically significant.
Results
Seventy-six subjects with essential hypertension were studied under both high-and low-salt conditions. Subject characteristics appear in Table 1 . Sixty-eight of the 76 subjects were classified as normal-to-high renin, as defined by an upright Table 2 provides blood-pressure, endocrine, and fibrinolytic data for subjects under conditions of high and low salt intake.
Effect of Salt Intake and PAI-1 Genotype on Blood-Pressure and Endocrine Parameters
Twenty-four-hour urinary sodium excretion was significantly lower during low salt intake than during high salt intake, whereas potassium excretion was higher. Systolic and diastolic blood pressures were significantly lower during low than during high salt intake. PRA, aldosterone, and cortisol concentrations were significantly increased during low salt intake compared with those measured during high salt intake.
There was no effect of salt intake on Ang II, fasting insulin, or glucose concentrations. There was a significant relationship between PAI-1 4G/5G genotype and serum cortisol concentration under high-salt conditions (Pϭ0.003, Table 3 ), but not under low-salt conditions. Fasting plasma glucose concentration measured under high-salt conditions also differed significantly among genotype groups (Pϭ0.04). There was no relationship between PAI-1 4G/5G genotype and body mass index, serum triglycerides, insulin, systolic or diastolic blood pressure, or any other endocrine parameter. Figure 1 illustrates the relationship between PAI-1 4G/5G genotype and PAI-1 antigen concentrations under high-and low-salt conditions. PAI-1 antigen measured during high salt intake correlated with that measured during low salt intake (R 2 ϭ0.05, PϽ0.001). Under either salt condition, PAI-1 antigen concentrations were highest in subjects homozygous for the 4G allele and lowest in those homozygous for the 5G allele (Table 3 ) (Fϭ7.6, Pϭ0.001 for effect of genotype by ANOVA). Overall, low salt intake was associated with an increased PAI-1 concentration compared with high salt intake (Figure 1 ; Fϭ6.0, Pϭ0.017 for effect of salt by ANOVA). 
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When subjects were stratified according to PAI-1 4G/5G genotype, however, the effect of salt on PAI-1 antigen concentrations was significant only in subjects who were homozygous for the 4G allele (Fϭ7.8, Pϭ0.001 for salt ϫ PAI-1 genotype interaction by ANOVA). Under low-salt conditions, there was no effect of PAI-1 4G/5G genotype on tPA antigen; thus, the molar ratio of PAI-1 to tPA increased with increasing numbers of 4G alleles (Table 3) . PAI-1 antigen, measured during either high or low salt intake, correlated with PAI-1 4G/5G genotype, body mass index, systolic blood pressure, plasma triglycerides, fasting glucose, fasting insulin, and PRA and aldosterone measured under salt-replete conditions (Tables 4 and 5) . During low salt intake, PAI-1 antigen also correlated with PRA and diastolic blood pressure. There was no relationship between PAI-1 antigen and age, sex, ethnicity, Ang II, urine potassium excretion, or cortisol under either high-or low-salt conditions. In multivariate regression models, body mass index and PAI-1 4G/4G genotype predicted PAI-1 antigen measured under either high-salt or low-salt conditions ( Table 6) . Under low-salt conditions, salt-replete aldosterone also predicted plasma PAI-1 antigen, whereas PRA and insulin predicted PAI-1 antigen under high-salt conditions.
To test the hypothesis that PAI-1 4G/5G genotype influences the relationship between triglycerides and circulating PAI-1 antigen concentrations in subjects with essential hypertension, we examined the relationship between PAI-1 antigen concentrations and triglycerides under both low-and high-salt conditions. Under both high-salt (R 2 ϭ0.31, Pϭ0.014) and low-salt (R 2 ϭ0.37, Pϭ0.006) conditions, PAI-1 antigen correlated with serum triglycerides in individuals homozygous for the PAI-1 4G allele, but not in those homozygous for the 5G allele or in heterozygotes ( Figure 2) . Under low-salt conditions, there appeared to be 2 subsets of data for the relationship between serum triglycerides and PAI-1 antigen in heterozygous subjects. These apparent subsets, however, were not defined by renin status, sex, ethnicity, or quartiles of body mass index, blood pressure, glucose, insulin, aldosterone, or Ang II. In 4G/4G subjects, the relationship between triglycerides and PAI-1 antigen Abbreviations as in Table 4 . Partial correlations were calculated after adjustment for triglycerides, glucose, and insulin. BMI indicates body mass index. Glucose, triglycerides, upright PRA, systolic blood pressure, PAI-1 5G/5G, and aldosterone did not reach statistical significance in the high-salt model (backward method, R 2 ϭ0.49, PϽ0.001). Glucose, insulin, triglycerides, systolic blood pressure, diastolic blood pressure, upright PRA, supine PRA during either low or high salt intake, and PAI-1 5G5G genotype did not reach statistical significance in the low-salt model (R 2 ϭ0.37, PϽ0.001). observed during low salt intake was similar to that observed during high salt intake (Pϭ0.19 for the comparison of the slopes of the lines).
Discussion
Activation of the RAAS by either salt depletion or diuretic treatment results in increased circulating PAI-1 antigen concentrations in healthy volunteers. 5, 25 The present study extends this observation to subjects with essential hypertension. More importantly, the study indicates that the 4G/5G polymorphism, located at Ϫ675 bp of the PAI-1 promoter, influences the effect of activation of the RAAS by salt depletion on circulating PAI-1 concentrations.
The finding that 4G/5G genotype modulates the effect of activation of the RAAS on circulating PAI-1 antigen concentrations has important implications for clinical studies. For example, ACE inhibitors have been found to reduce PAI-1 antigen concentrations in many, 5,26 -30 but not all, studies. 31, 32 The present data suggest that the effect of ACE inhibition on PAI-1 antigen concentrations and fibrinolytic balance may depend on the PAI-1 4G/5G genotype frequencies in the population studied. On the basis of the finding that salt depletion caused the greatest increase in PAI-1 antigen in 4G/4G subjects, the effect of ACE inhibition on circulating PAI-1 antigen would be expected to be greatest in individuals homozygous for the 4G allele.
Conversely, the results of this study suggest that activity of the RAAS influences the relationship between PAI-1 4G/5G genotype and PAI-1 antigen concentrations. Thus, the relationship between 4G/5G genotype and circulating PAI-1 antigen concentrations was attenuated under high-salt conditions, when PRA and aldosterone are suppressed, compared with under low-salt conditions. Given that renin activity decreases with age, 33 the finding that activation of the RAAS accentuates the relationship between the PAI-1 genotype and PAI-1 antigen concentrations may explain the observed association between PAI-1 4G/5G genotype and MI in young, 10 but not older, 19, 20 populations. Although there was no relationship between age and PAI-1 antigen concentrations in the present study, the study population was relatively young, and all but 8 subjects had normal to high PRA.
This study does not specifically address the mechanism for the interactive effect of PAI-1 genotype and salt intake on PAI-1 antigen. Salt depletion was associated with activation of the RAAS, as measured by both PRA and aldosterone concentrations. Although plasma Ang II concentrations were not increased during low salt intake, this finding may reflect the relatively small number of subjects in whom Ang II was measured or difficulties in accurately measuring Ang II because of its short half-life. 34 We have previously observed that PAI-1 antigen concentrations correlate with PRA and aldosterone concentrations in normotensive subjects. 5 In the present study, PAI-1 antigen correlated with PRA and aldosterone under high-salt conditions and with PRA alone under low-salt conditions. Although mean cortisol concentration was higher during low salt intake than during high salt intake and serum cortisol concentration increased with the number of PAI-1 4G alleles under high-salt conditions, there was no correlation between cortisol and PAI-1 antigen under either low-or high-salt conditions. Both Ang II (or its hexapeptide metabolite, Ang IV) and aldosterone increase PAI-1 expression in a variety of cell types, including astrocytes, 35 endothelial cells, 4 vascular smooth muscle cells, 36 proximal tubular epithelial cells, 37 and mesangial cells. 38 Systemic infusion of Ang II increases vascular, renal, and hepatic PAI-1 expression in rats, 39 whereas treatment of animals with ACE inhibitors, AT 1 receptor antagonists, or aldosterone receptor antagonists decreases tissue PAI-1 expression. 15, 40 Ang II stimulates PAI-1 expression through a serum-inducible element localized to a sequence between Ϫ47 and Ϫ38 bp in the PAI-1 promoter. 41 Functional studies suggest the presence of 2 steroidresponsive elements in the PAI-1 promoter: one between Ϫ64 and Ϫ59 bp and a second farther upstream. 42 Additional studies are needed to examine how the binding of transcription activators and repressors at the Ϫ675 PAI-1 4G/5G locus might influence Ang II-and aldosterone-induced PAI-1 expression.
Studies of the relationship between blood pressure and fibrinolytic balance may be confounded by the association of hypertension with insulin resistance. Two large cohort studies, however, suggest an independent association between blood pressure and PAI-1. 43, 44 In the Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) study of 1558 men and women, high PAI-1 activity correlated with diastolic blood pressure in men, but not women, after control for anthropomorphic characteristics and lipid levels. 43 In a study of the Framingham Offspring Population, PAI-1 activity correlated with systolic and diastolic blood pressure in 1193 men and 1459 women, even after control for triglycerides, body mass index, and diabetes. 44 In the present study, PAI-1 activity correlated with systolic blood pressure during both low and high salt intake, but this correlation was no longer significant after adjustment for triglycerides or body mass index. The lack of association between blood pressure and PAI-1 in the adjusted analysis may reflect the small sample size compared with the previous cohort studies as well as the substantial effect of insulin resistance on PAI-1.
Previous studies have demonstrated that PAI-1 4G/5G genotype influences the relationship between serum triglycerides and PAI-1 antigen in diabetic patients, such that triglycerides and PAI-1 antigen correlate in individuals who are homozygous for the 4G allele but not in individuals who carry Ն1 copy of the 5G allele. 22 This genotype-specific effect of triglycerides has been attributed to the interaction of the PAI-1 4G/5G site and an adjacent VLDL triglyceridesensitive site in the promoter region of the PAI-1 gene. 45 In this study, we observed a similar genotype-specific effect of triglycerides on PAI-1 antigen in nondiabetic subjects with essential hypertension. Significantly, salt intake did not alter the interactive effect of PAI-1 4G/5G genotype and triglycerides on PAI-1 antigen concentrations, consistent with a localized interaction between the 4G/5G locus and VLDLresponsive element.
In summary, previous studies demonstrate that activation of RAAS is associated with both increased PAI-1 antigen concentrations and increased risk of thrombotic cardiovascular events. The present study indicates that genetic variation at the PAI-1 4G/5G locus modulates the effect of activation of the RAAS by salt depletion on circulating PAI-1 antigen concentrations. The study identifies an important gene-byenvironment interaction that may influence both cardiovascular morbidity and the response to pharmacological approaches that interrupt the RAAS.
